☰

Jocelyn C. Reader, Ph.D. - Publications

Affiliations: 
2009 Human Genetics University of Maryland School of Medicine, Baltimore, MD, United States 
Area:
Genetics
Tree Info Similar researchers PubMed Report error

32 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Smith PG, Roque D, Ching MM, Fulton A, Rao G, Reader JC. The Role of Eicosanoids in Gynecological Malignancies. Frontiers in Pharmacology. 11: 1233. PMID 32982722 DOI: 10.3389/Fphar.2020.01233  0.381
2020 Ching MM, Reader J, Fulton AM. Eicosanoids in Cancer: Prostaglandin E Receptor 4 in Cancer Therapeutics and Immunotherapy. Frontiers in Pharmacology. 11: 819. PMID 32547404 DOI: 10.3389/Fphar.2020.00819  0.441
2020 Reader J, Ching M, Fan C(, Wu S, Staats P, Legesse T, Goloubeva O, Jian N, Carey M, Fulton A, Roque D, Rao G. Abstract B67: Analysis of function and inhibition of PGE2 pathway members MRP4 and EP4 in treatment of ovarian cancer Clinical Cancer Research. 26. DOI: 10.1158/1557-3265.Ovca19-B67  0.394
2019 Reader J, Harper AK, Legesse T, Staats PN, Goloubeva O, Rao GG, Fulton A, Roque DM. EP4 and Class III β-Tubulin Expression in Uterine Smooth Muscle Tumors: Implications for Prognosis and Treatment. Cancers. 11. PMID 31635323 DOI: 10.3390/Cancers11101590  0.322
2019 Kundu N, Ma X, Brox R, Fan X, Kochel T, Reader J, Tschammer N, Fulton A. The Chemokine Receptor CXCR3 Isoform B Drives Breast Cancer Stem Cells. Breast Cancer : Basic and Clinical Research. 13: 1178223419873628. PMID 31619923 DOI: 10.1177/1178223419873628  0.355
2018 Fan CA, Reader J, Roque DM. Review of Immune Therapies Targeting Ovarian Cancer. Current Treatment Options in Oncology. 19: 74. PMID 30430276 DOI: 10.1007/S11864-018-0584-3  0.305
2017 Kundu N, Brox R, Ma X, Reader J, Tschammer N, Fulton AM. Abstract 4770: Novel CXCR3 allosteric modulators inhibit breast cancer stem cells and metastasis Cancer Research. 77: 4770-4770. DOI: 10.1158/1538-7445.Am2017-4770  0.435
2016 Kochel TJ, Reader JC, Ma X, Kundu N, Fulton AM. Multiple drug resistance-associated protein (MRP4) exports prostaglandin E2 (PGE2) and contributes to metastasis in basal/triple negative breast cancer. Oncotarget. PMID 28029661 DOI: 10.18632/Oncotarget.14145  0.435
2016 Kochel T, Ma X, Kundu N, Reader J, Goloubeva O, Fulton AM. Abstract 4132: Multiple drug resistance-associated protein 4 (MRP4): Role in triple negative breast cancer Cancer Research. 76: 4132-4132. DOI: 10.1158/1538-7445.Am2016-4132  0.34
2015 Li Y, Reader JC, Ma X, Kundu N, Kochel T, Fulton AM. Divergent roles of CXCR3 isoforms in promoting cancer stem-like cell survival and metastasis. Breast Cancer Research and Treatment. 149: 403-15. PMID 25537642 DOI: 10.1007/S10549-014-3229-7  0.416
2015 Fulton A, Kundu N, Kochel T, Ma X, Reader J. Abstract P2-06-03: Prostaglandin E receptor EP4 is a therapeutic target in breast cancer stem cells Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P2-06-03  0.444
2015 Reader JC, Ma X, Kundu N, Goloubeva O, Fulton A. Abstract 3250: Prostaglandin E2 receptor EP1 suppresses breast cancer metastasis Cancer Research. 75: 3250-3250. DOI: 10.1158/1538-7445.Am2015-3250  0.44
2015 Fulton AM, Kundu N, Ma X, Kochel T, Reader J. Abstract 2233: The prostaglandin E receptor EP4 is upregulated on breast cancer stem-like cells and regulates sensitivity to Natural Killer cells Cancer Research. 75: 2233-2233. DOI: 10.1158/1538-7445.Am2015-2233  0.447
2015 Li Y, Reader JC, Ma X, Kundu N, Kochel T, Fulton AM. Abstract 1531: Distinct roles of CXCR3 isoforms in promoting breast cancer stem-like cell properties and metastasis Cancer Research. 75: 1531-1531. DOI: 10.1158/1538-7445.Am2015-1531  0.418
2014 Kundu N, Ma X, Kochel T, Goloubeva O, Staats P, Thompson K, Martin S, Reader J, Take Y, Collin P, Fulton A. Prostaglandin E receptor EP4 is a therapeutic target in breast cancer cells with stem-like properties. Breast Cancer Research and Treatment. 143: 19-31. PMID 24281828 DOI: 10.1007/S10549-013-2779-4  0.439
2013 Ma X, Holt D, Kundu N, Reader J, Goloubeva O, Take Y, Fulton AM. A prostaglandin E (PGE) receptor EP4 antagonist protects natural killer cells from PGE2-mediated immunosuppression and inhibits breast cancer metastasis. Oncoimmunology. 2: e22647. PMID 23482441 DOI: 10.4161/Onci.22647  0.38
2013 Rao GG, Kochel T, Kundu N, Reader J, Fulton A. Abstract 524: Cyclooxygenase pathway in ovarian cancer. Cancer Research. 73: 524-524. DOI: 10.1158/1538-7445.Am2013-524  0.412
2013 Kochel TJ, Reader J, Kundu N, Li Y, Ma X, Holt D, Fulton A. Abstract 5119: Multiple drug resistance-associated protein 4 (MRP4) may contribute to breast cancer progression by exporting the COX-2 product PGE2. Cancer Research. 73: 2257-2257. DOI: 10.1158/1538-7445.Am2013-5119  0.451
2013 Reader JC, Ma X, Kundu N, Goloubeva O, Fulton A. Abstract 3862: Mechanistic studies of the metastasis suppressor prostaglandin E2 receptor EP1 in breast cancer. Cancer Research. 73: 3862-3862. DOI: 10.1158/1538-7445.Am2013-3862  0.436
2011 Reader J, Holt D, Fulton A. Prostaglandin E2 EP receptors as therapeutic targets in breast cancer. Cancer Metastasis Reviews. 30: 449-63. PMID 22002714 DOI: 10.1007/S10555-011-9303-2  0.399
2011 Yu L, Reader JC, Chen C, Zhao XF, Ha JS, Lee C, York T, Gojo I, Baer MR, Ning Y. Activation of a novel palmitoyltransferase ZDHHC14 in acute biphenotypic leukemia and subsets of acute myeloid leukemia. Leukemia. 25: 367-71. PMID 21151021 DOI: 10.1038/Leu.2010.271  0.502
2011 Li Y, Reader J, Ma X, Kundu N, Kao JP, Zhan S, Fulton AM. Abstract 2434: CXCR3-mediated cellular and molecular events involved in breast cancer metastasis Cancer Research. 71: 2434-2434. DOI: 10.1158/1538-7445.Am2011-2434  0.444
2011 Kochel T, Kundu N, Ma X, Reader J, Brodie A, Fulton AM. Abstract 1472: MRP4 and PGT, members of the COX-2 pathway, may contribute to breast cancer progression Cancer Research. 71: 1472-1472. DOI: 10.1158/1538-7445.Am2011-1472  0.442
2011 Reader JC, Ma X, Kundu N, Goloubeva O, Kao J, Fulton A. Abstract 1456: Prostaglandin E2 receptor EP1 as a metastasis suppressor in breast cancer Cancer Research. 71: 1456-1456. DOI: 10.1158/1538-7445.Am2011-1456  0.444
2010 Ma X, Kundu N, Ioffe OB, Goloubeva O, Konger R, Baquet C, Gimotty P, Reader J, Fulton AM. Prostaglandin E receptor EP1 suppresses breast cancer metastasis and is linked to survival differences and cancer disparities. Molecular Cancer Research : McR. 8: 1310-8. PMID 20858737 DOI: 10.1158/1541-7786.Mcr-10-0003  0.433
2010 Reader JC, Leng Q, Rassool FV, Ning Y. Regulation of differentiation by a PHD domain in the NUP98-PHF23 fusion protein. Leukemia Research. 34: 1094-7. PMID 20219246 DOI: 10.1016/J.Leukres.2010.02.015  0.518
2010 Ning Y, Yu L, Reader J, Chen C, Zhao XF, Ha JS, Lee C, York T, Gojo I, Baer MR. Activation of a Novel Palmitoyltransferase through a t(6;14) Translocation In T/Myeloid Biphenotypic Leukemia and Subsets of Acute Myeloid Leukemia. Blood. 116: 1663-1663. DOI: 10.1182/Blood.V116.21.1663.1663  0.585
2010 Fulton AM, Ma X, Kundu N, Ioffe O, Goloubeva O, Konger R, Baquet C, Reader J. Abstract 5764: Opposing roles of the COX-2 pathway receptors EP1 and EP4 in metastasis and contribution to disparities Cancer Research. 70: 5764-5764. DOI: 10.1158/1538-7445.Am10-5764  0.425
2007 Chang H, Qi X, Xu W, Reader JC, Ning Y. Analysis of 6q deletion in Waldenstrom macroglobulinemia. European Journal of Haematology. 79: 244-7. PMID 17655703 DOI: 10.1111/J.1600-0609.2007.00903.X  0.533
2007 Reader JC, Meekins JS, Gojo I, Ning Y. A novel NUP98-PHF23 fusion resulting from a cryptic translocation t(11;17)(p15;p13) in acute myeloid leukemia. Leukemia. 21: 842-4. PMID 17287853 DOI: 10.1038/Sj.Leu.2404579  0.521
2006 Chang H, Qi X, Trieu Y, Xu W, Reader JC, Ning Y, Reece D. Multiple myeloma patients with CKS1B gene amplification have a shorter progression-free survival post-autologous stem cell transplantation. British Journal of Haematology. 135: 486-91. PMID 16995883 DOI: 10.1111/J.1365-2141.2006.06325.X  0.547
2006 Reader JC, Zhao XF, Butler MS, Rapoport AP, Ning Y. REL-positive double minute chromosomes in follicular lymphoma. Leukemia. 20: 1624-6. PMID 16775615 DOI: 10.1038/Sj.Leu.2404289  0.505
Show low-probability matches.